The burgeoning popularity of semaglutide , initially for blood sugar control , is creating significant interest within the British Isles, prompting a notable shift in peptide trends. Access these treatments remains a complex landscape, with NHS approval currently limited and private clinics offering prescriptions at a premium . Questions are bei⦠Read More